Find your missing element with Thermo Fisher Scientific Drug development requires science, technology, and expertise. But it also requires a strategic CDMO partnership—bonded by several intangible elements. Choosing a CDMO partner Learn more Insights and resources for the pharma services industry Lear...
Thermo Fisher Scientific pharma services has over 60 locations across 24 countries 463,000 463,000+ clinical shipments completed in 2022, providing the tools needed to execute clinical trials to accelerate the delivery of safe, high-quality medicines to patients 30 purpose-built GMP facilities Global...
Find your missing element with Thermo Fisher Scientific Drug development requires science, technology, and expertise. But it also requires a strategic CDMO partnership—bonded by several intangible elements. Choosing a CDMO partner Learn more Insights and resources for the pharma services industry Lear...
At Thermo Fisher Scientific, we serve the pharmaceutical, biotech, and life sciences industries as a strategic contract development and manufacturing organization (CDMO) and clinical services partner. We believe that strategic partnerships fuel success, and we embed the elements of partnership into every...
Thermo Fisher Scientific opens viral vector manufacturing facility in Plainville, Massachusetts. Learn More >> Search Contact us Innovative solutions Integrated offerings Customizable solutions backed by a science-driven, risk-based approach to reduce development timelines. ...
Our facility in Pretoria, South Africa serves as a gateway to clinical trials in South Africa and Sub-Saharan Africa.
Through Patheon pharma services, Thermo Fisher Scientific provides CDMO services for drug development, clinical trial logistics, and commercial manufacturing to customers.
Thermo Fisher Scientific and Innoforce have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China, for integrated biologics and steriles drug development and manufacturing. The new facility is expected to be completed in 2022. ...
Thermo Fisher Scientific Inc. and Innoforce announced they have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China, for integrated biologics and steriles drug development and manufacturing. The new facility is expected to be completed in 2022 and will ...
ABOUT THERMO FISHER SCIENTIFIC Thermo Fisher is a leading global provider of bioprocessing solutions. We simplify the development path and accelerate our customers’ innovations to bring therapies to patients, faster. With our comprehensive portfolio of products and services we are a dedicated partner th...